Search

everythinglearnresearchcommunity

for

Search:↓

Men with enlarged prostates often have more severe baldness.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Finasteride-loaded nanoparticles may help treat alopecia.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Scientists created a gel with nanoparticles to deliver medicine to hair follicles effectively.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Hair loss in balding individuals is linked to changes in specific hair growth-related genes.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.